These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18444920)

  • 21. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
    O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
    Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes.
    Hering BJ; Kandaswamy R; Ansite JD; Eckman PM; Nakano M; Sawada T; Matsumoto I; Ihm SH; Zhang HJ; Parkey J; Hunter DW; Sutherland DE
    JAMA; 2005 Feb; 293(7):830-5. PubMed ID: 15713772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes.
    Rother KI; Spain LM; Wesley RA; Digon BJ; Baron A; Chen K; Nelson P; Dosch HM; Palmer JP; Brooks-Worrell B; Ring M; Harlan DM
    Diabetes Care; 2009 Dec; 32(12):2251-7. PubMed ID: 19808924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study.
    Vantyghem MC; Chetboun M; Gmyr V; Jannin A; Espiard S; Le Mapihan K; Raverdy V; Delalleau N; Machuron F; Hubert T; Frimat M; Van Belle E; Hazzan M; Pigny P; Noel C; Caiazzo R; Kerr-Conte J; Pattou F;
    Diabetes Care; 2019 Nov; 42(11):2042-2049. PubMed ID: 31615852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved long-term health-related quality of life after islet transplantation.
    Tharavanij T; Betancourt A; Messinger S; Cure P; Leitao CB; Baidal DA; Froud T; Ricordi C; Alejandro R
    Transplantation; 2008 Nov; 86(9):1161-7. PubMed ID: 19005394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary graft function, metabolic control, and graft survival after islet transplantation.
    Vantyghem MC; Kerr-Conte J; Arnalsteen L; Sergent G; Defrance F; Gmyr V; Declerck N; Raverdy V; Vandewalle B; Pigny P; Noel C; Pattou F
    Diabetes Care; 2009 Aug; 32(8):1473-8. PubMed ID: 19638525
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.
    Toso C; Baertschiger R; Morel P; Bosco D; Armanet M; Wojtusciszyn A; Badet L; Philippe J; Becker CD; Hadaya K; Majno P; Bühler L; Berney T;
    Am J Transplant; 2006 May; 6(5 Pt 1):1049-58. PubMed ID: 16611343
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Islet of Langerhans transplantation for the treatment of type 1 diabetes.
    Bucher P; Mathe Z; Bosco D; Andres A; Bühler LH; Morel P; Berney T
    Swiss Surg; 2003; 9(5):242-6. PubMed ID: 14601328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International trial of the Edmonton protocol for islet transplantation.
    Shapiro AM; Ricordi C; Hering BJ; Auchincloss H; Lindblad R; Robertson RP; Secchi A; Brendel MD; Berney T; Brennan DC; Cagliero E; Alejandro R; Ryan EA; DiMercurio B; Morel P; Polonsky KS; Reems JA; Bretzel RG; Bertuzzi F; Froud T; Kandaswamy R; Sutherland DE; Eisenbarth G; Segal M; Preiksaitis J; Korbutt GS; Barton FB; Viviano L; Seyfert-Margolis V; Bluestone J; Lakey JR
    N Engl J Med; 2006 Sep; 355(13):1318-30. PubMed ID: 17005949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term insulin independence following repeated islet transplantation in totally pancreatectomized diabetic pigs.
    Morsiani E; Fogli L; Lanza G; Lebow LT; Demetriou AA; Rozga J
    Cell Transplant; 2002; 11(1):55-66. PubMed ID: 12095221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-year follow-up after clinical islet transplantation.
    Ryan EA; Paty BW; Senior PA; Bigam D; Alfadhli E; Kneteman NM; Lakey JR; Shapiro AM
    Diabetes; 2005 Jul; 54(7):2060-9. PubMed ID: 15983207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report.
    Yang HK; Ham DS; Park HS; Rhee M; You YH; Kim MJ; Kim JW; Lee SH; Hong TH; Choi BG; Cho JH; Yoon KH
    J Korean Med Sci; 2015 Jul; 30(7):991-4. PubMed ID: 26130966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction.
    Faradji RN; Froud T; Messinger S; Monroy K; Pileggi A; Mineo D; Tharavanij T; Mendez AJ; Ricordi C; Alejandro R
    Cell Transplant; 2009; 18(10):1247-59. PubMed ID: 20003758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
    Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
    Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.
    Posselt AM; Bellin MD; Tavakol M; Szot GL; Frassetto LA; Masharani U; Kerlan RK; Fong L; Vincenti FG; Hering BJ; Bluestone JA; Stock PG
    Am J Transplant; 2010 Aug; 10(8):1870-80. PubMed ID: 20659093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
    Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
    Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-Term Follow-Up of the Edmonton Protocol of Islet Transplantation in the United States.
    Brennan DC; Kopetskie HA; Sayre PH; Alejandro R; Cagliero E; Shapiro AM; Goldstein JS; DesMarais MR; Booher S; Bianchine PJ
    Am J Transplant; 2016 Feb; 16(2):509-17. PubMed ID: 26433206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial.
    Lablanche S; Vantyghem MC; Kessler L; Wojtusciszyn A; Borot S; Thivolet C; Girerd S; Bosco D; Bosson JL; Colin C; Tetaz R; Logerot S; Kerr-Conte J; Renard E; Penfornis A; Morelon E; Buron F; Skaare K; Grguric G; Camillo-Brault C; Egelhofer H; Benomar K; Badet L; Berney T; Pattou F; Benhamou PY;
    Lancet Diabetes Endocrinol; 2018 Jul; 6(7):527-537. PubMed ID: 29776895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.